PRIME-XS
PRIME-XS (Proteomics Research Infrastructure Maximizing knowledge EXchange and access) was a significant European collaborative project in the field of proteomics that operated from 2011 to 2015, coordinated by the NPC. Funded by the European Union's Seventh Framework Programme, PRIME-XS established a coordinated network of leading proteomics facilities across Europe.
The project's primary goal was to provide European researchers with access to state-of-the-art proteomics technologies and expertise. Through an open application process, scientists could submit proposals to utilize the advanced mass spectrometry platforms, protein analysis methods, and bioinformatics tools available at the participating centers.
PRIME-XS also focused on harmonizing proteomics methodologies, developing quality control standards, and creating shared data repositories. The initiative facilitated knowledge exchange through workshops, training courses, and collaborative research projects.
By integrating resources and expertise across national boundaries, PRIME-XS significantly advanced European capabilities in protein research and supported numerous breakthrough studies in biomedicine, plant sciences, and biotechnology.
EPIC-XS
From 2019 to 2024, the NPC coordinated EPIC-XS (European Proteomics Infrastructure Consortium - Providing Access), a project funded under the Horizon 2020 programme to further strengthen access to proteomics facilities in Europe.
The consortium included fifteen partner institutions across eleven European countries. EPIC-XS offered trans-national access to advanced mass spectrometry platforms, protein characterization methods, and specialized bioinformatics tools through a competitive application process.
Beyond providing technology access, EPIC-XS focused on standardization of proteomics workflows, development of innovative methodologies, and comprehensive training programs. The infrastructure supported research in diverse fields including biomedicine, food science, and environmental studies.
EASI-OMICS
In 2026 EASI-OMICS has been awarded funding from the Horizon Europe Program. The project will start at the end of 2026 and will run until 2030. The NPC is part of the consortium, together with 6 partners from Spain, Sweden and Belgium, led by the CNAG, Barcelona.
EASI-OMICS: Integrated Multi-Omics Services for Next Generation Biomedical Research will support biomedical researchers across Europe by providing access to cutting-edge multi-omics technologies and integrated analyses. The project responds to key barriers in the field, including disciplinary silos, rapid technological change, complex data integration, high costs, and unequal access to advanced omics infrastructures.
Through a centralised Transnational Access framework, EASI-OMICS will launch three competitive open calls and support at least 50 ambitious biomedical research projects. These projects will use complementary omics technologies across areas such as disease mechanisms, biomarker discovery and validation, drug response, and clinical translation.
The project will also train researchers in data management, metadata standards, integrative analysis, and innovation, while establishing a FAIR-compliant framework for managing and integrating multi-omics datasets. By combining genomics, transcriptomics, epigenomics, proteomics, bioinformatics, and translational medicine expertise, EASI-OMICS aims to place Europe at the forefront of biomedical multi-omics research and innovation.